Oral contraceptives and primary liver cancer.
作者信息
La Vecchia C, Negri E, Parazzini F
机构信息
Mario Negri Institute for Pharmacological Research, Milan, Italy.
出版信息
Br J Cancer. 1989 Mar;59(3):460-1. doi: 10.1038/bjc.1989.94.
Abstract
摘要
相似文献
1
Oral contraceptives and primary liver cancer.口服避孕药与原发性肝癌
Br J Cancer. 1989 Mar;59(3):460-1. doi: 10.1038/bjc.1989.94.
2
Female hormone utilisation and risk of hepatocellular carcinoma.女性激素的使用与肝细胞癌风险
Br J Cancer. 1993 Mar;67(3):635-7. doi: 10.1038/bjc.1993.116.
3
Oral contraceptives as related to cancer and benign lesions of the breast.口服避孕药与乳腺癌及乳腺良性病变的关系
J Natl Cancer Inst. 1975 Oct;55(4):767-73. doi: 10.1093/jnci/55.4.767.
4
Oral contraceptive use and invasive cervical cancer.口服避孕药的使用与浸润性宫颈癌
Int J Epidemiol. 1990 Jun;19(2):259-63. doi: 10.1093/ije/19.2.259.
5
Epidemiology of hepatocellular adenoma. The role of oral contraceptive use.肝细胞腺瘤的流行病学。口服避孕药的作用。
JAMA. 1979 Aug 17;242(7):644-8.
6
Oral contraceptive use and liver cancer.口服避孕药的使用与肝癌
Am J Epidemiol. 1989 Nov;130(5):878-82. doi: 10.1093/oxfordjournals.aje.a115420.
7
Oral contraception and risk of a cerebral thromboembolic attack: results of a case-control study.口服避孕药与脑栓塞发作风险：一项病例对照研究的结果
BMJ. 1993 Apr 10;306(6883):956-63. doi: 10.1136/bmj.306.6883.956.
8
The risk of liver neoplasia in relation to combined oral contraceptive use.与联合使用口服避孕药相关的肝脏肿瘤风险。
Contraception. 1991 Jun;43(6):643-52. doi: 10.1016/0010-7824(91)90007-3.
9
Relative and attributable risk for cervical cancer: a comparative study in the United States and Italy.宫颈癌的相对风险和归因风险：美国与意大利的一项对比研究。
Int J Epidemiol. 1990 Sep;19(3):539-45. doi: 10.1093/ije/19.3.539.
10
Case-control study of oral contraceptives and risk of thromboembolic stroke: results from International Study on Oral Contraceptives and Health of Young Women.口服避孕药与血栓栓塞性中风风险的病例对照研究：年轻女性口服避孕药与健康国际研究的结果
BMJ. 1997 Dec 6;315(7121):1502-4. doi: 10.1136/bmj.315.7121.1502.
引用本文的文献
1
Menstrual Factors, Reproductive History and Liver Cancer Risk: Findings from a Prospective Cohort Study in Chinese Women.月经因素、生育史与肝癌风险：中国女性前瞻性队列研究的结果。
Cancer Epidemiol Biomarkers Prev. 2022 Nov 2;31(11):2046-2053. doi: 10.1158/1055-9965.EPI-22-0439.
2
Effect of oestrogen/gestagen replacement therapy on liver enzymes in patients with Ullrich-Turner syndrome.
Eur J Pediatr. 1995 Oct;154(10):807-10. doi: 10.1007/BF01959786.
3
Female hormone utilisation and risk of hepatocellular carcinoma.女性激素的使用与肝细胞癌风险
Br J Cancer. 1993 Mar;67(3):635-7. doi: 10.1038/bjc.1993.116.
4
Cumulative risk of hepatocellular carcinoma in hepatitis C virus carriers: statistical estimations from cross-sectional data.丙型肝炎病毒携带者肝细胞癌的累积风险：基于横断面数据的统计估计
Jpn J Cancer Res. 1994 May;85(5):485-90. doi: 10.1111/j.1349-7006.1994.tb02384.x.
5
Trends in mortality from primary liver cancer in England and Wales 1975-92: influence of oral contraceptives.1975 - 1992年英格兰和威尔士原发性肝癌死亡率趋势：口服避孕药的影响
Br J Cancer. 1995 Sep;72(3):800-3. doi: 10.1038/bjc.1995.415.
6
Cancer mortality in young adults: Italy 1955-1985.意大利1955 - 1985年青年成年人的癌症死亡率
J Cancer Res Clin Oncol. 1990;116(2):215-9. doi: 10.1007/BF01612680.
7
The relationship between oral contraceptive use, cancer and vascular disease.口服避孕药的使用与癌症及血管疾病之间的关系。
Drug Saf. 1990 Nov-Dec;5(6):436-46. doi: 10.2165/00002018-199005060-00004.
8
Risk for malignant tumors after oral contraceptive use: is it related to organ size while taking the pill?口服避孕药使用后发生恶性肿瘤的风险：这与服药期间的器官大小有关吗？
Med Oncol Tumor Pharmacother. 1990;7(1):61-4. doi: 10.1007/BF03000492.
9
Oral contraceptives and primary liver cancer among young women.年轻女性中的口服避孕药与原发性肝癌
Cancer Causes Control. 1992 Jan;3(1):43-8. doi: 10.1007/BF00051911.
10
Liveborn children and risk of hepatocellular carcinoma.活产儿与肝细胞癌风险
Cancer Causes Control. 1992 Mar;3(2):171-4. doi: 10.1007/BF00051657.
本文引用的文献
1
Trends in mortality from carcinoma of the liver and the use of oral contraceptives.肝癌死亡率趋势与口服避孕药的使用情况
Br J Cancer. 1983 Sep;48(3):349-54. doi: 10.1038/bjc.1983.199.
2
Hepatocellular carcinoma and oral contraceptives.肝细胞癌与口服避孕药
Br J Cancer. 1983 Sep;48(3):437-40. doi: 10.1038/bjc.1983.210.
3
Studies on the role of oral contraceptive use in the etiology of benign and malignant liver tumors.关于口服避孕药在良性和恶性肝肿瘤病因学中作用的研究。
J Surg Oncol. 1981;18(1):73-85. doi: 10.1002/jso.2930180112.
4
Oral contraceptive steroids as promoters of hepatocarcinogenesis in female Sprague-Dawley rats.口服避孕甾体激素作为雌性斯普拉格-道利大鼠肝癌发生的促进剂。
Cancer Res. 1980 Oct;40(10):3680-5.
5
Trends in cancer mortality in Italy, 1955-1978.1955 - 1978年意大利癌症死亡率趋势
Tumori. 1985 Jun 30;71(3):201-18. doi: 10.1177/030089168507100301.
6
Determinants of oral contraceptive use in northern Italy.意大利北部口服避孕药使用的决定因素。
Contraception. 1986 Aug;34(2):145-56. doi: 10.1016/0010-7824(86)90067-3.
7
A case-control study of diet and gastric cancer in northern Italy.意大利北部饮食与胃癌的病例对照研究。
Int J Cancer. 1987 Oct 15;40(4):484-9. doi: 10.1002/ijc.2910400409.
8
Oral contraceptives and hepatocellular carcinoma.口服避孕药与肝细胞癌
Br Med J (Clin Res Ed). 1986 May 24;292(6532):1355-7. doi: 10.1136/bmj.292.6532.1355.
9
Risk factors for hepatocellular carcinoma in northern Italy.意大利北部肝细胞癌的危险因素。
Int J Cancer. 1988 Dec 15;42(6):872-6. doi: 10.1002/ijc.2910420614.
Zotero 插件